THE SENSITIVITY OF BOVINE CORNEAL EPITHELIAL LYSO-PAF ACETYLTRANSFERASE TO CYCLOOXYGENASE AND LIPOXYGENASE INHIBITORS IS INDEPENDENT OF ARACHIDONATE METABOLITES
Js. Hurst et Hep. Bazan, THE SENSITIVITY OF BOVINE CORNEAL EPITHELIAL LYSO-PAF ACETYLTRANSFERASE TO CYCLOOXYGENASE AND LIPOXYGENASE INHIBITORS IS INDEPENDENT OF ARACHIDONATE METABOLITES, Journal of ocular pharmacology and therapeutics, 13(5), 1997, pp. 415-426
Lyso-platelet-activating factor (PAF) acetyltransferase is a critical
regulatory step in PAF synthesis. PAF accumulates in the cornea in res
ponse to injury and is a potent inflammatory mediator that stimulates
corneal cyclooxygenase but not lipoxygenase reactions. 12(S)-hydroxyei
cosatetraenoic (HETE) acid, a major lipoxygenase product of mammalian
corneas, is also generated during injury. In the bovine corneal epithe
lium, both PAF acetyltransferase and 12-lipoxygenase are microsomal en
zymes. A potential interaction between these two lipid mediators was,
therefore, examined. PAF acetyltransferase activity was assayed by det
ermining radioactivity in the trichloroacetic acid-precipitated comple
x of [H-3]PAF bound to albumin, formed after incubation of corneal epi
thelial microsomes with lyso-PAF and [H-3]acetyl CoA. Lipoxygenase met
abolism by bovine corneal epithelial microsomes was also studied. Whil
e 12(S)-HETE did not activate lyso-PAF acetyltransferase, PAF synthesi
s was decreased when microsomes were treated with lipoxygenase inhibit
ors. The IC50 values for nordihydroguaiaretic acid (NDGA), and baicale
in were 75 and 105 mu M, respectively. The IC50 value for CDC, a more
potent inhibitor of platelet 12-lipoxygenase, was greater than 200 mu
M. The results indicate that concentrations suppressing lyso-PAF acety
ltransferase activity exceed those required to inhibit lipoxygenases f
rom bovine corneal epithelia. Similarly, concentrations of aspirin and
indomethacin, cyclooxygenase inhibitors that decrease PAF formation,
were greater than those reported to block prostaglandin generation. A
number of other compounds, some structurally similar to the lipoxygena
se inhibitors that suppress lyso-PAF acetyltransferase, and others unr
elated chemically but known as anti-oxidant and cationic-chelators, al
so inhibited lyso-PAF acetyltransferase. This suggests that lyso-PAF a
cetyltransferase activity is inhibited by mechanisms independent of li
poxygenase and cyclooxygenase metabolites.